Repare Therapeutics Ownership 2024 | Who Owns Repare Therapeutics Now?
Institutional Ownership
16.14%
Insider Ownership
0.95%
Retail Ownership
82.90%
Institutional Holders
16.00
Repare Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 24.47% | 0.96% | 10,333,600 | - | - | 34,100,880 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 7.99% | 3.10% | 3,372,499 | 250,000 | 8.01% | 11,129,247 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 7.87% | 0.22% | 3,322,488 | - | - | 10,964,210 | Jun 30, 2024 |
| VERSANT VENTURE MANAGEMENT, LLC | 6.27% | 11.30% | 2,646,657 | - | - | 8,733,968 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 6.23% | 0.08% | 2,630,364 | -73,419 | -2.72% | 8,680,201 | Jun 30, 2024 |
| MPM ASSET MANAGEMENT LLC | 5.31% | 4.06% | 2,242,636 | - | - | 7,400,699 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 4.60% | 0.39% | 1,942,555 | -73,747 | -3.66% | 6,410,432 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 3.88% | 0.84% | 1,639,849 | - | - | 5,411,502 | Jun 30, 2024 |
| AQUILO CAPITAL MANAGEMENT, LLC | 2.27% | 3.04% | 956,932 | 323,661 | 51.11% | 3,157,876 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 2.14% | 0.09% | 904,261 | -1,780,083 | -66.31% | 2,984,061 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.09% | 0.00% | 458,700 | 107,700 | 30.68% | 1,513,710 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.99% | 0.00% | 417,929 | 284,036 | 212.14% | 1,373,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.71% | 0.07% | 299,654 | 173,446 | 137.43% | 989,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.70% | 0.00% | 295,760 | 8,231 | 2.86% | 976,007 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 0.66% | 0.00% | 277,168 | -31,281 | -10.14% | 914,654 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 0.66% | 0.01% | 277,168 | -31,281 | -10.14% | 914,654 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.59% | 0.00% | 249,475 | 80,610 | 47.74% | 823,267 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.35% | 0.00% | 149,574 | 29,441 | 24.51% | 493,594 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.34% | 0.00% | 142,974 | 115,916 | 428.40% | 471,814 | Jun 30, 2024 |
| BLACKROCK INC. | 0.34% | - | 141,803 | 80,538 | 131.46% | 467,950 | Jun 30, 2024 |
Repare Therapeutics's largest institutional shareholder is BVF INC/IL, holding 24.47% of the company's total share outstanding, currently valued at $34.10M. The top 10 institutional shareholders own together 71.01% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VERSANT VENTURE MANAGEMENT, LLC | 6.27% | 11.30% | 2,646,657 | - | - | 8,733,968 | Jun 30, 2024 |
| MPM ASSET MANAGEMENT LLC | 5.31% | 4.06% | 2,242,636 | - | - | 7,400,699 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 7.99% | 3.10% | 3,372,499 | 250,000 | 8.01% | 11,129,247 | Jun 30, 2024 |
| AQUILO CAPITAL MANAGEMENT, LLC | 2.27% | 3.04% | 956,932 | 323,661 | 51.11% | 3,157,876 | Jun 30, 2024 |
| BVF INC/IL | 24.47% | 0.96% | 10,333,600 | - | - | 34,100,880 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 3.88% | 0.84% | 1,639,849 | - | - | 5,411,502 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 4.60% | 0.39% | 1,942,555 | -73,747 | -3.66% | 6,410,432 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 7.87% | 0.22% | 3,322,488 | - | - | 10,964,210 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.18% | 0.13% | 75,091 | 28,868 | 62.45% | 247,800 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 2.14% | 0.09% | 904,261 | -1,780,083 | -66.31% | 2,984,061 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 6.23% | 0.08% | 2,630,364 | -73,419 | -2.72% | 8,680,201 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.71% | 0.07% | 299,654 | 173,446 | 137.43% | 989,000 | Jun 30, 2024 |
| HARBOURVEST PARTNERS LLC | 0.03% | 0.02% | 12,276 | - | - | 40,511 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 0.66% | 0.01% | 277,168 | -31,281 | -10.14% | 914,654 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 33,320 | 33,320 | 100.00% | 109,956 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.07% | 0.01% | 30,038 | -42 | -0.14% | 99,125 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.99% | 0.00% | 417,929 | 284,036 | 212.14% | 1,373,000 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.10% | 0.00% | 41,632 | -12,953 | -23.73% | 137,386 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.09% | 0.00% | 458,700 | 107,700 | 30.68% | 1,513,710 | Jun 30, 2024 |
| IEQ CAPITAL, LLC | 0.09% | 0.00% | 38,382 | 38,382 | 100.00% | 126,661 | Jun 30, 2024 |
The largest Repare Therapeutics shareholder by % of total assets is VERSANT VENTURE MANAGEMENT, LLC. The company owns 2.65M shares of Repare Therapeutics (RPTX), representing 11.30% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AQUILO CAPITAL MANAGEMENT, LLC | 2.27% | 3.04% | 956,932 | 323,661 | 51.11% | 3,157,876 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.99% | 0.00% | 417,929 | 284,036 | 212.14% | 1,373,000 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 7.99% | 3.10% | 3,372,499 | 250,000 | 8.01% | 11,129,247 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.71% | 0.07% | 299,654 | 173,446 | 137.43% | 989,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.34% | 0.00% | 142,974 | 115,916 | 428.40% | 471,814 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.09% | 0.00% | 458,700 | 107,700 | 30.68% | 1,513,710 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.20% | 0.00% | 82,590 | 82,590 | 100.00% | 272,549 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.59% | 0.00% | 249,475 | 80,610 | 47.74% | 823,267 | Jun 30, 2024 |
| BLACKROCK INC. | 0.34% | - | 141,803 | 80,538 | 131.46% | 467,950 | Jun 30, 2024 |
| IEQ CAPITAL, LLC | 0.09% | 0.00% | 38,382 | 38,382 | 100.00% | 126,661 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 33,320 | 33,320 | 100.00% | 109,956 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.35% | 0.00% | 149,574 | 29,441 | 24.51% | 493,594 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.18% | 0.13% | 75,091 | 28,868 | 62.45% | 247,800 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.04% | 0.00% | 14,763 | 14,763 | 100.00% | 48,718 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.03% | 0.00% | 13,600 | 13,600 | 100.00% | 44,880 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.19% | 0.00% | 78,382 | 11,629 | 17.42% | 258,661 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.05% | 0.00% | 21,900 | 9,400 | 75.20% | 72,270 | Jun 30, 2024 |
| MORGAN STANLEY | 0.70% | 0.00% | 295,760 | 8,231 | 2.86% | 976,007 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.09% | 0.00% | 37,900 | 7,500 | 24.67% | 125,070 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.26% | 0.00% | 110,935 | 5,673 | 5.39% | 438,193 | Jun 30, 2024 |
As of Jun 30 2024, Repare Therapeutics's largest institutional buyer is AQUILO CAPITAL MANAGEMENT, LLC. The company purchased 323.66K stocks of RPTX, valued at $3.16M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 2.14% | 0.09% | 904,261 | -1,780,083 | -66.31% | 2,984,061 | Jun 30, 2024 |
| ARTAL GROUP S.A. | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | - | - | - | -344,328 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -165,173 | -100.00% | - | Jun 30, 2024 |
| REDMILE GROUP, LLC | 4.60% | 0.39% | 1,942,555 | -73,747 | -3.66% | 6,410,432 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 6.23% | 0.08% | 2,630,364 | -73,419 | -2.72% | 8,680,201 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -67,561 | -100.00% | - | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -60,659 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -35,418 | -100.00% | - | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 0.66% | 0.01% | 277,168 | -31,281 | -10.14% | 914,654 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 0.66% | 0.00% | 277,168 | -31,281 | -10.14% | 914,654 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.03% | - | 13,265 | -27,504 | -67.46% | 43,774 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -25,826 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -21,076 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.05% | - | 20,169 | -16,118 | -44.42% | 66,558 | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -15,443 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.10% | 0.00% | 41,632 | -12,953 | -23.73% | 137,386 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.02% | - | 10,254 | -12,565 | -55.06% | 33,838 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -10,956 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -7,637 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Repare Therapeutics's biggest institutional seller is DEEP TRACK CAPITAL, LP. The company sold -1.78M shares of RPTX, valued at $2.98M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IEQ CAPITAL, LLC | 0.09% | 0.00% | 38,382 | 38,382 | 100.00% | 126,661 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 33,320 | 33,320 | 100.00% | 109,956 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.04% | 0.00% | 14,763 | 14,763 | 100.00% | 48,718 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.03% | 0.00% | 13,600 | 13,600 | 100.00% | 44,880 | Jun 30, 2024 |
Repare Therapeutics's largest new institutional shareholder by number of shares is IEQ CAPITAL, LLC, purchased 38.38K shares, valued at $126.66K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | - | - | - | -344,328 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -165,173 | -100.00% | - | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -67,561 | -100.00% | - | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -60,659 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -35,418 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -25,826 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -21,076 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -15,443 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -10,956 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -7,637 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -2,045 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -1,005 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -518 | -100.00% | - | Jun 30, 2024 |
Repare Therapeutics's largest sold out institutional shareholder by shares sold is ARTAL GROUP S.A., sold -0.70M shares, valued at -, as of undefined.
Repare Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Clough Global Equity Fund | 1.23% | 76,400 | - | - | Jan 31, 2024 |
| Clough Global Opportunities Fund | 0.36% | 143,579 | - | - | Jan 31, 2024 |
| Ark ETF Trust | 0.34% | 2,750,042 | 181,182 | 7.05% | Jan 31, 2024 |
| Clough Funds Trust | 0.29% | 11,800 | - | - | Jan 31, 2023 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.10% | 380,700 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.09% | 770,077 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.08% | 615,139 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.06% | 29,150 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.03% | 96,272 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.02% | 56,500 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 212,400 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 617,099 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 6,808 | - | - | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.00% | 292,200 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 21,002 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 110,968 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 24,418 | - | - | Jan 31, 2024 |
| Harbor ETF Trust | 0.00% | 13,689 | -2,581 | -15.86% | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 138,200 | - | - | Feb 29, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.00% | 19,732 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 26,506 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 37,400 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 19,700 | - | - | Mar 31, 2024 |
| HARBOR FUNDS | 0.00% | 32,173 | -2,613 | -7.51% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 10,800 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 59,021 | - | - | Jan 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 18,031 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 77,660 | - | - | Feb 29, 2024 |
| Franklin Custodian Funds | 0.00% | 400,000 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 15,983 | 2,561 | 19.08% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 10,387 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 80,600 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 29,878 | 8,375 | 38.95% | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 63,457 | 354 | 0.56% | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 373 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.00% | 1,524 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 26,544 | - | - | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 10,846 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 19,805 | -7,496 | -27.46% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 18,239 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 3,930 | - | - | Mar 28, 2024 |
| Voya MUTUAL FUNDS | 0.00% | 4,513 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 14,227 | 717 | 5.31% | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 228,993 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 13,913 | - | - | Dec 31, 2023 |
| Series Portfolios Trust | 0.00% | 71 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,685 | - | - | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 26,585 | - | - | Mar 28, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 427 | - | - | Dec 31, 2023 |
| VICTORY PORTFOLIOS | 0.00% | 214 | - | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 3,460 | 1,229 | 55.09% | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 746 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 2,000 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 3,050 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 3,400 | - | - | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 42,041 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 2,271 | - | - | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 3,509 | - | - | Feb 29, 2024 |
Repare Therapeutics's largest mutual fund holder by % of total assets is "Clough Global Equity Fund", owning 76.40K shares, compromising 1.23% of its total assets.
Repare Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 16 | -78.38% |
| 31 Mar, 24 | 74 | 4.23% |
| 31 Dec, 23 | 71 | -15.48% |
| 30 Sep, 23 | 84 | 6.33% |
| 30 Jun, 23 | 79 | - |
| 31 Mar, 23 | 79 | -5.95% |
| 31 Dec, 22 | 84 | 20.00% |
| 30 Sep, 22 | 70 | -5.41% |
| 30 Jun, 22 | 74 | 19.35% |
| 31 Mar, 22 | 62 | -6.06% |
| 31 Dec, 21 | 66 | -5.71% |
| 30 Sep, 21 | 70 | 12.90% |
| 30 Jun, 21 | 62 | - |
| 31 Mar, 21 | 62 | 3.33% |
| 31 Dec, 20 | 60 | 71.43% |
| 30 Sep, 20 | 35 | -27.08% |
| 30 Jun, 20 | 48 | 4700.00% |
| 31 Mar, 20 | 1 | - |
| 31 Dec, 19 | 1 | - |
| 30 Sep, 19 | 1 | - |
| 30 Jun, 19 | 1 | - |
| 31 Mar, 19 | 1 | - |
As of 30 Jun 24, 16 institutions are holding Repare Therapeutics's shares, representing a decrease of -78.38% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,818,077 | -80.80% |
| 31 Mar, 24 | 35,510,875 | -2.75% |
| 31 Dec, 23 | 36,515,547 | 0.76% |
| 30 Sep, 23 | 36,240,790 | 1.19% |
| 30 Jun, 23 | 35,815,655 | 7.87% |
| 31 Mar, 23 | 33,202,698 | -0.71% |
| 31 Dec, 22 | 33,438,591 | 1.87% |
| 30 Sep, 22 | 32,824,729 | -1.25% |
| 30 Jun, 22 | 33,240,877 | 1.95% |
| 31 Mar, 22 | 32,605,371 | -0.25% |
| 31 Dec, 21 | 32,685,691 | 21.25% |
| 30 Sep, 21 | 26,957,494 | 1.61% |
| 30 Jun, 21 | 26,531,052 | 2.11% |
| 31 Mar, 21 | 25,981,600 | 4.07% |
| 31 Dec, 20 | 24,965,497 | 4.65% |
| 30 Sep, 20 | 23,857,007 | 3.64% |
| 30 Jun, 20 | 23,020,216 | 23020116.00% |
| 31 Mar, 20 | 100 | - |
| 31 Dec, 19 | 100 | - |
| 30 Sep, 19 | 100 | - |
| 30 Jun, 19 | 100 | - |
| 31 Mar, 19 | 100 | - |
Repare Therapeutics (RPTX) has 6.82M shares outstanding as of 30 Jun 24, down -80.80% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 16.14% | 0.23% |
| 31 Mar, 24 | 84.27% | 1.12% |
| 31 Dec, 23 | 86.73% | 1.17% |
| 30 Sep, 23 | 86.10% | 1.19% |
| 30 Jun, 23 | 85.19% | 1.37% |
| 31 Mar, 23 | 78.98% | 1.24% |
| 31 Dec, 22 | 79.76% | 1.30% |
| 30 Sep, 22 | 78.26% | 1.24% |
| 30 Jun, 22 | 79.33% | 1.31% |
| 31 Mar, 22 | 77.89% | 1.04% |
| 31 Dec, 21 | 86.43% | 1.64% |
| 30 Sep, 21 | 72.62% | 1.42% |
| 30 Jun, 21 | 71.63% | 1.45% |
| 31 Mar, 21 | 70.38% | 0.45% |
| 31 Dec, 20 | 124.54% | 0.88% |
| 30 Sep, 20 | 119.01% | 1.21% |
| 30 Jun, 20 | 99.26% | 57550540000.00% |
| 31 Mar, 20 | 0.00% | 250000.00% |
| 31 Dec, 19 | 0.00% | 250000.00% |
| 30 Sep, 19 | 0.00% | 250000.00% |
| 30 Jun, 19 | 0.00% | 250000.00% |
| 31 Mar, 19 | 0.00% | - |
As of 30 Jun 24, Repare Therapeutics is held by 16.14% institutional shareholders, representing a 0.23% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -86.36% |
| 31 Mar, 24 | 22 | -31.25% |
| 31 Dec, 23 | 32 | 3.23% |
| 30 Sep, 23 | 31 | 3.33% |
| 30 Jun, 23 | 30 | 3.45% |
| 31 Mar, 23 | 29 | -27.50% |
| 31 Dec, 22 | 40 | 37.93% |
| 30 Sep, 22 | 29 | -21.62% |
| 30 Jun, 22 | 37 | 19.35% |
| 31 Mar, 22 | 31 | -22.50% |
| 31 Dec, 21 | 40 | 17.65% |
| 30 Sep, 21 | 34 | 30.77% |
| 30 Jun, 21 | 26 | -35.00% |
| 31 Mar, 21 | 40 | 2.56% |
| 31 Dec, 20 | 39 | 129.41% |
| 30 Sep, 20 | 17 | -63.83% |
| 30 Jun, 20 | 47 | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
| 30 Sep, 19 | - | - |
| 30 Jun, 19 | - | -100.00% |
| 31 Mar, 19 | 1 | - |
3 institutional shareholders have increased their position in RPTX stock as of 30 Jun 24 compared to 22 in the previous quarter (a -86.36% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 6 | -76.92% |
| 31 Mar, 24 | 26 | 23.81% |
| 31 Dec, 23 | 21 | 5.00% |
| 30 Sep, 23 | 20 | -23.08% |
| 30 Jun, 23 | 26 | 13.04% |
| 31 Mar, 23 | 23 | - |
| 31 Dec, 22 | 23 | - |
| 30 Sep, 22 | 23 | 15.00% |
| 30 Jun, 22 | 20 | 25.00% |
| 31 Mar, 22 | 16 | 14.29% |
| 31 Dec, 21 | 14 | -36.36% |
| 30 Sep, 21 | 22 | 10.00% |
| 30 Jun, 21 | 20 | 66.67% |
| 31 Mar, 21 | 12 | - |
| 31 Dec, 20 | 12 | 71.43% |
| 30 Sep, 20 | 7 | - |
| 30 Jun, 20 | - | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
| 30 Sep, 19 | - | - |
| 30 Jun, 19 | - | - |
| 31 Mar, 19 | - | - |
6 institutional shareholders have reduced their position in RPTX stock as of 30 Jun 24 compared to 26 in the previous quarter (a -76.92% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 16 | -78.38% | 6,818,077 | -80.80% | 16.14% | 0.23% | 3 | -86.36% | 6 | -76.92% |
| 31 Mar, 24 | 74 | 4.23% | 35,510,875 | -2.75% | 84.27% | 1.12% | 22 | -31.25% | 26 | 23.81% |
| 31 Dec, 23 | 71 | -15.48% | 36,515,547 | 0.76% | 86.73% | 1.17% | 32 | 3.23% | 21 | 5.00% |
| 30 Sep, 23 | 84 | 6.33% | 36,240,790 | 1.19% | 86.10% | 1.19% | 31 | 3.33% | 20 | -23.08% |
| 30 Jun, 23 | 79 | - | 35,815,655 | 7.87% | 85.19% | 1.37% | 30 | 3.45% | 26 | 13.04% |
| 31 Mar, 23 | 79 | -5.95% | 33,202,698 | -0.71% | 78.98% | 1.24% | 29 | -27.50% | 23 | - |
| 31 Dec, 22 | 84 | 20.00% | 33,438,591 | 1.87% | 79.76% | 1.30% | 40 | 37.93% | 23 | - |
| 30 Sep, 22 | 70 | -5.41% | 32,824,729 | -1.25% | 78.26% | 1.24% | 29 | -21.62% | 23 | 15.00% |
| 30 Jun, 22 | 74 | 19.35% | 33,240,877 | 1.95% | 79.33% | 1.31% | 37 | 19.35% | 20 | 25.00% |
| 31 Mar, 22 | 62 | -6.06% | 32,605,371 | -0.25% | 77.89% | 1.04% | 31 | -22.50% | 16 | 14.29% |
| 31 Dec, 21 | 66 | -5.71% | 32,685,691 | 21.25% | 86.43% | 1.64% | 40 | 17.65% | 14 | -36.36% |
| 30 Sep, 21 | 70 | 12.90% | 26,957,494 | 1.61% | 72.62% | 1.42% | 34 | 30.77% | 22 | 10.00% |
| 30 Jun, 21 | 62 | - | 26,531,052 | 2.11% | 71.63% | 1.45% | 26 | -35.00% | 20 | 66.67% |
| 31 Mar, 21 | 62 | 3.33% | 25,981,600 | 4.07% | 70.38% | 0.45% | 40 | 2.56% | 12 | - |
| 31 Dec, 20 | 60 | 71.43% | 24,965,497 | 4.65% | 124.54% | 0.88% | 39 | 129.41% | 12 | 71.43% |
| 30 Sep, 20 | 35 | -27.08% | 23,857,007 | 3.64% | 119.01% | 1.21% | 17 | -63.83% | 7 | - |
| 30 Jun, 20 | 48 | 4700.00% | 23,020,216 | 23020116.00% | 99.26% | 57550540000.00% | 47 | - | - | - |
| 31 Mar, 20 | 1 | - | 100 | - | 0.00% | 250000.00% | - | - | - | - |
| 31 Dec, 19 | 1 | - | 100 | - | 0.00% | 250000.00% | - | - | - | - |
| 30 Sep, 19 | 1 | - | 100 | - | 0.00% | 250000.00% | - | - | - | - |
| 30 Jun, 19 | 1 | - | 100 | - | 0.00% | 250000.00% | - | -100.00% | - | - |
| 31 Mar, 19 | 1 | - | 100 | - | 0.00% | - | 1 | - | - | - |
Repare Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Repare Therapeutics's stock was made by Segal Lloyd Mitchell on Apr 01 2024, selling 2,650 shares at $4.62 per share (valued at $12.24K).
Repare Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 4 | - |
| Q1 2024 | 8 | 16 | 50.00% |
| Q4 2023 | 11 | 2 | 550.00% |
| Q2 2023 | 9 | 2 | 450.00% |
| Q1 2023 | 8 | - | - |
| Q4 2022 | 8 | 8 | 100.00% |
| Q2 2022 | 26 | 25 | 104.00% |
| Q1 2022 | 8 | 1 | 800.00% |
| Q4 2021 | 7 | 10 | 70.00% |
| Q3 2021 | 8 | 70 | 11.43% |
| Q2 2021 | 29 | 129 | 22.48% |
| Q1 2021 | 75 | 54 | 138.89% |
| Q4 2020 | 11 | 38 | 28.95% |
| Q2 2020 | 65 | 34 | 191.18% |
0 total buy trades, and 4 total sell trades (buy/sell ratio of 0.00%) were made by Repare Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 4 | - |
| Q1 2024 | - | 16 | - |
| Q4 2023 | 9 | - | - |
| Q2 2023 | - | 3 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 1 | - |
| Q2 2022 | 3 | 13 | 23.08% |
| Q1 2022 | 3 | 1 | 300.00% |
| Q4 2021 | 1 | 2 | 50.00% |
| Q3 2021 | - | 64 | - |
| Q2 2021 | - | 105 | - |
| Q1 2021 | - | 2 | - |
| Q4 2020 | - | 15 | - |
| Q2 2020 | 18 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Repare Therapeutics's stocks.
RPTX Ownership FAQ
Who Owns Repare Therapeutics?
Repare Therapeutics is owned by institutional shareholders (16.14%), insiders (0.95%), and public (82.90%). The largest institutional shareholder of Repare Therapeutics is BVF INC/IL (24.47% of total shares) and the top mutual fund owner is Clough Global Equity Fund (1.23% of total shares).
Who are the major institutional shareholders of Repare Therapeutics?
Repare Therapeutics's major institutional shareholders are BVF INC/IL, BLUE OWL CAPITAL HOLDINGS LP, ORBIMED ADVISORS LLC, VERSANT VENTURE MANAGEMENT, LLC, and ARK INVESTMENT MANAGEMENT LLC. The top five shareholders own together 52.81% of the company's share outstanding.
How many Repare Therapeutics shareholders are there?
As of Jun 2024, there are 16 institutional shareholders of Repare Therapeutics.
What percentage of Repare Therapeutics is owned by BVF INC/IL?
BVF INC/IL owns 10.33M shares of Repare Therapeutics, representing 24.47% of the company's total shares outstanding, valued at $34.1M (as of Jun 2024).
What percentage of Repare Therapeutics is owned by BLUE OWL CAPITAL HOLDINGS LP?
As of Jun 2024, BLUE OWL CAPITAL HOLDINGS LP holds 3.37M shares of Repare Therapeutics (RPTX), compromising 7.99% of the company, valued at $11.13M.
What percentage of Repare Therapeutics is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC is the third largest holder of Repare Therapeutics. The company owns 3.32M of the company's shares outstanding (worth $10.96M).